Venture Life Group plc (AIM:VLG)
London · Delayed Price · Currency is GBP · Price in GBX 58.00
-0.50 (-0.85%)
Jul 28, 2025, 4:35 PM GMT+1
Venture Life Group Revenue
In the year 2024, Venture Life Group had annual revenue of 26.59M GBP with 18.90% growth.
Revenue
26.59M
Revenue Growth
-46.81%
P/S Ratio
2.82
Revenue / Employee
618.44K
Employees
43
Market Cap
74.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 26.59M | 4.23M | 18.90% |
| Dec 31, 2023 | 22.37M | -21.62M | -49.15% |
| Dec 31, 2022 | 43.98M | 11.22M | 34.24% |
| Dec 31, 2021 | 32.76M | 2.69M | 8.93% |
| Dec 31, 2020 | 30.08M | 9.87M | 48.85% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 42.56B |
| GSK plc | 31.53B |
| Haleon | 11.23B |
| Smith & Nephew | 4.64B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |